Lecture: “OregonHeart: Developing a total artificial heart,” May 28

The Knight Cardiovascular Institute invites you to attend “OregonHeart: Developing a total artificial heart,” a lecture providing an overview of the KCVI’s new company aimed at developing a successful total artificial heart device to treat patients with end-stage heart failure. OregonHeart’s Chief Scientific Officer and renowned inventor of the Hemopump, Richard Wampler, will present, along with other company representatives and OHSU faculty collaborators.

Thursday, May 28, 2015
5 to 6:30 p.m.
Collaborative Life Sciences Building, room 2S060

Light reception to follow.

Bookmark and Share


  1. This presentation is intended to provide an overview of this remarkable project, and to inform regarding the disease, heart pumps, and early-stage medical device ventures. It will also include:
    -Dr. Albert Starr; vision and goals
    -Dr. Howard Song & Dr. Jim Mudd; application of mechanical circulatory support in end-stage heart failure, role of artificial heart in therapy
    -Bob Benkowski; medical device development
    -Clyde Taylor; the Company and business issues relevant to commercial device development.

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.